-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Misses Q4 EPS by 29c
-
-
-
-
-
-
-
Harmony Biosciences raises 2025 revenue guidance on strong WAKIX sales
-
-
-
-
-
-
-
Harmony Biosciences (HRMY) Tops Q1 EPS by 42c, provides guidance
-
-
-
-
-
-
-
Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
-
-
-
-
-
-
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
-
-
-
-
-
-
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
-
-
-
-
-
-
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023
-
1,205,333 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

